Adaptive Cardiac Resynchronization Therapy Study

The trial has 3 primary end points: * to demonstrate that over 6-month follow-up, the proportion of the patients improved in the aCRT arm is at least as high as in the Echo arm * to demonstrate that cardiac function is similar when using aCRT versus echo-optimized settings * to demonstrate that aCRT does not result in inappropriate AV or VV delay settings